Spots Global Cancer Trial Database for gastroesophageal junction carcinoma
Every month we try and update this database with for gastroesophageal junction carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer | NCT05563766 | Esophageal Aden... Esophageal Squa... Gastroesophagea... | Itraconazole | 18 Years - | VA Office of Research and Development | |
| Clinical Study of Nab-paclitaxel Combined With Toripalimab in Local Advanced or Metastatic G/GEJ Carcinoma | NCT04443036 | Gastric Carcino... | Albumin-Bound P... Toripalimab | 18 Years - 70 Years | China Medical University, China | |
| Study of Pembrolizumab (MK-3475) as First-Line Monotherapy and Combination Therapy for Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-062/KEYNOTE-062) | NCT02494583 | Gastric Adenoca... | Pembrolizumab Cisplatin 5-FU Capecitabine Placebo | 18 Years - | Merck Sharp & Dohme LLC | |
| A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer | NCT04254107 | Non-small Cell ... Gastric Carcino... Gastroesophagea... Classical Hodgk... Diffuse Large B... Peripheral T-ce... Cutaneous Melan... Head and Neck S... Bladder Cancer Ovarian Cancer Triple Negative... Cervical Cancer | SEA-TGT sasanlimab brentuximab ved... | 18 Years - | Seagen Inc. | |
| A Study of SGN-STNV in Advanced Solid Tumors | NCT04665921 | Carcinoma, Non-... HER2 Negative B... Ovarian Neoplas... Uterine Cervica... Endometrial Neo... Esophageal Neop... Gastroesophagea... Stomach Neoplas... Colorectal Neop... Exocrine Pancre... Appendiceal Ade... Pseudomyxoma Pe... | SGN-STNV | 18 Years - | Seagen Inc. | |
| A Study to Evaluate Nivolumab in the Treatment of Early Stage Esophageal or Gastroesophageal Cancer | NCT05780736 | Esophageal Carc... Gastroesophagea... | 18 Years - | Bristol-Myers Squibb | ||
| A Study to Evaluate Nivolumab in the Treatment of Early Stage Esophageal or Gastroesophageal Cancer | NCT05780736 | Esophageal Carc... Gastroesophagea... | 18 Years - | Bristol-Myers Squibb | ||
| Study of TJ033721 in Subjects With Advanced or Metastatic Solid Tumors | NCT04900818 | Solid Tumor Advanced Cancer Metastatic Canc... Gastric Cancer Gastroesophagea... Esophageal Aden... | TJ033721 | 18 Years - | I-Mab Biopharma US Limited | |
| A Study of SGN-ALPV in Advanced Solid Tumors | NCT05229900 | Ovarian Neoplas... Endometrial Neo... Carcinoma, Non-... Stomach Neoplas... Gastroesophagea... Uterine Cervica... Testicular Neop... | SGN-ALPV | 18 Years - | Seagen Inc. | |
| ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation | NCT05059444 | Bladder Carcino... Ureter Carcinom... Renal Pelvis Ca... Non-small Cell ... Invasive Breast... Cutaneous Melan... Esophageal Carc... Gastroesophagea... Gastric Adenoca... Pancreatic Aden... Squamous Cell C... Epithelial Ovar... Fallopian Tube ... Endometrial Car... Renal Cell Carc... | Guardant Reveal | 18 Years - | Guardant Health, Inc. | |
| Clinical Study of Nab-paclitaxel Combined With Toripalimab in Local Advanced or Metastatic G/GEJ Carcinoma | NCT04443036 | Gastric Carcino... | Albumin-Bound P... Toripalimab | 18 Years - 70 Years | China Medical University, China | |
| ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation | NCT05059444 | Bladder Carcino... Ureter Carcinom... Renal Pelvis Ca... Non-small Cell ... Invasive Breast... Cutaneous Melan... Esophageal Carc... Gastroesophagea... Gastric Adenoca... Pancreatic Aden... Squamous Cell C... Epithelial Ovar... Fallopian Tube ... Endometrial Car... Renal Cell Carc... | Guardant Reveal | 18 Years - | Guardant Health, Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
